Seeking Alpha

Alan Robert Ross'  Instablog

Alan Robert Ross
Send Message
I started investing while getting my Ph.D. at McGill University. My research was on behavioral correlates of neurological control of cardiovascular function. After 25 years as a Professor, I quit to do something more exciting and more difficult: live off of my investments. For quite some time, I... More
My company:
Trust Intelligence
My blog:
Trust Intelligence
  • PCYC's Imbruvica Gets Approved By FDA With Less Data & More Serious Side-Effects Than PV-10 1 comment
    Feb 14, 2014 11:34 AM | about stocks: PVCT

    While the bashers will not allow contrary facts to change their negative thesis, it makes sense that shareholders and prospective shareholders consider FDA actions in comparable situations in forming an opinion of the likely course of PV-10 to ultimate approval and commercialization. Here is one situation where the data are arguably weaker than that for PV-10 and the FDA has approved the drug.

    Note that this drug was approved based upon Phase I/ IIb trial of less than 50 patients (as opposed to PV-10 Phase II with 80 patients).

    It was a single arm trial, like that for PV-10.

    Overall response rate with just shy of 59%, which is lower than PV-10's for treated tumors and patients where all tumors were treated.

    And, unlike the relatively safety of PV=10, some of the side effects were quite serious: hemorrhage, infections, myelosuppression, renal toxicity, second primary malignancies and embryo-fetal toxicity.

    For the full details, click here.

    Disclosure: I am long PVCT.

    Stocks: PVCT
Back To Alan Robert Ross' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • Nick Santa
    , contributor
    Comments (373) | Send Message
    I was wondering how this compared to PV-10. Thanks Alan.
    14 Feb 2014, 09:10 PM Reply Like
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.